Chargement en cours...
Epac is Required for GLP-1R-Mediated Inhibition of Oxidative Stress and Apoptosis in Cardiomyocytes
Although the cardioprotective effects of glucagon-like peptide-1 and its analogs have been reported, the exact mechanisms of the glucagon-like peptide-1 receptor (GLP-1R) signaling pathway in the heart are still unclear. Activation of the GLP-1R has been shown to increase cAMP levels, thus eliciting...
Enregistré dans:
| Publié dans: | Mol Endocrinol |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Endocrine Society
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5414745/ https://ncbi.nlm.nih.gov/pubmed/25719403 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/me.2014-1346 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|